Silent
Missense
Nonsense
Frequency of SNVs in pancancer level
| Cancer | Full Name | Mutation | Mutation Type | Sample Number |
|---|---|---|---|---|
| BLCA | Bladder urothelial carcinoma | D208Y | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | N228K | Missense | 1 |
| CESC | Cervical and endocervical cancers | D215Y | Missense | 1 |
| COAD | Colon adenocarcinoma | E170* | Nonsense | 1 |
| COAD | Colon adenocarcinoma | G245E | Missense | 1 |
| COAD | Colon adenocarcinoma | R77C | Missense | 1 |
| COAD | Colon adenocarcinoma | S191N | Missense | 1 |
| COAD | Colon adenocarcinoma | T186M | Missense | 1 |
| ESCA | Esophageal carcinoma | L158L | Silent | 1 |
| ESCA | Esophageal carcinoma | Q12E | Missense | 1 |
| ESCA | Esophageal carcinoma | S184I | Missense | 1 |
| ESCA | Esophageal carcinoma | T186M | Missense | 1 |
| HNSC | Head and Neck squamous cell carcinoma | G243A | Missense | 1 |
| LUAD | Lung adenocarcinoma | Y73C | Missense | 1 |
| PAAD | Pancreatic adenocarcinoma | I137L | Missense | 1 |
| SARC | Sarcoma | E65K | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | E263K | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | P145L | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | R192R | Silent | 1 |
| STAD | Stomach adenocarcinoma | E247D | Missense | 1 |
| STAD | Stomach adenocarcinoma | G176R | Missense | 1 |
| STAD | Stomach adenocarcinoma | H118Y | Missense | 1 |
| STAD | Stomach adenocarcinoma | R136T | Missense | 1 |
| STAD | Stomach adenocarcinoma | S183L | Missense | 1 |
| STAD | Stomach adenocarcinoma | T180M | Missense | 1 |
| TGCT | Testicular Germ Cell Tumors | G32V | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | A31V | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | E170K | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | E43D | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | E65D | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | F99C | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | Q41P | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | S184I | Missense | 1 |
Mutational percentage of Silent, Missense and Nonsense for various cancers
Summary of mutation in pancancer level
| Cancer | Full Name | # Sample | % Silent | % Missense | % Nonsense |
|---|---|---|---|---|---|
| BLCA | Bladder urothelial carcinoma | 394 | 0 | 6.7 | 0 |
| BRCA | Breast invasive carcinoma | 976 | 0 | 0 | 0 |
| CESC | Cervical and endocervical cancers | 194 | 0 | 3.3 | 0 |
| COAD | Colon adenocarcinoma | 367 | 0 | 13.3 | 100 |
| ESCA | Esophageal carcinoma | 185 | 50 | 10 | 0 |
| GBM | Glioblastoma multiforme | 283 | 0 | 0 | 0 |
| HNSC | Head and Neck squamous cell carcinoma | 511 | 0 | 3.3 | 0 |
| KIRC | Kidney renal clear cell carcinoma | 476 | 0 | 0 | 0 |
| KIRP | Kidney renal papillary cell carcinoma | 282 | 0 | 0 | 0 |
| LAML | Acute Myeloid Leukemia | 192 | 0 | 0 | 0 |
| LGG | Brain Lower Grade Glioma | 516 | 0 | 0 | 0 |
| LIHC | Liver hepatocellular carcinoma | 373 | 0 | 0 | 0 |
| LUAD | Lung adenocarcinoma | 533 | 0 | 3.3 | 0 |
| LUSC | Lung squamous cell carcinoma | 177 | 0 | 0 | 0 |
| OV | Ovarian serous cystadenocarcinoma | 465 | 0 | 0 | 0 |
| PAAD | Pancreatic adenocarcinoma | 126 | 0 | 3.3 | 0 |
| PCPG | Pheochromocytoma and Paraganglioma | 179 | 0 | 0 | 0 |
| PRAD | Prostate adenocarcinoma | 498 | 0 | 0 | 0 |
| READ | Rectum adenocarcinoma | 122 | 0 | 0 | 0 |
| SARC | Sarcoma | 247 | 0 | 3.3 | 0 |
| SKCM | Skin Cutaneous Melanoma | 290 | 50 | 6.7 | 0 |
| STAD | Stomach adenocarcinoma | 393 | 0 | 20 | 0 |
| TGCT | Testicular Germ Cell Tumors | 147 | 0 | 3.3 | 0 |
| THCA | Thyroid carcinoma | 495 | 0 | 0 | 0 |
| THYM | Thymoma | 119 | 0 | 0 | 0 |
| UCEC | Uterine Corpus Endometrial Carcinoma | 248 | 0 | 23.3 | 0 |